ADVERTISEMENT
News
InnovaMatrix AC - Convatec
09/24/2024
A 120-patient RCT will examine the efficacy of porcine placental extracellular matrix as an adjunct to SoC vs SoC alone for hard-to-heal VLUs with the primary outcome being percentage of ulcer closure at 12 weeks. Not yet recruiting; estimated study completion is April 2026. clinicaltrials.gov
